Related references
Note: Only part of the references are listed.A Systematic Review and Meta-Analysis of the Significance of Body Mass Index on Kidney Cancer Outcomes
Lawrence H. Kim et al.
JOURNAL OF UROLOGY (2021)
Epidemiology of Renal Cell Carcinoma
Umberto Capitanio et al.
EUROPEAN UROLOGY (2019)
Impact of body mass index (BMI) on treatment outcomes to immune checkpoint blockade (ICB) in metastatic renal cell carcinoma (mRCC).
Aly-Khan A. Lalani et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation
Andres F. Correa et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations
Laurence Albiges et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Body Mass Index, Diabetes, and Mortality in French Women Explaining Away a Paradox
Martin Lajous et al.
EPIDEMIOLOGY (2014)
Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories A Systematic Review and Meta-analysis
Katherine M. Flegal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
An Epidemiologic and Genomic Investigation Into the Obesity Paradox in Renal Cell Carcinoma
A. Ari Hakimi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Obesity paradox or inappropriate study designs? Time for life-course epidemiology
Isabel Ferreira et al.
JOURNAL OF HYPERTENSION (2012)
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
Andrew G. Renehan et al.
LANCET (2008)
Share Paper
